Global Custom Market Research Reports Provider Company

phone

Regulus Therapeutics Inc. (RGLS) - Financial and Strategic SWOT Analysis Review

  • Published Date: 01 Feb 2015
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America

Summary

Regulus Therapeutics Inc. (Regulus Therapeutics) is a biopharmaceutical company. The company discovers, develops and commercializes microRNA based therapeutics. It develops single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target microRNAs. The company’s products are used for the therapeutic conditions of hepatitis C infection, cardiovascular disease, cancer, fibrosis, immune inflammatory diseases, and metabolic diseases. Regulus Therapeutics is also optimizing anti miRs in several distinct programs, both independently and with its strategic alliance partners, AstraZeneca, GlaxoSmithKline and Sanofi. It was formed by the two companies, Isis Pharmaceuticals and Alnylam Pharmaceuticals. Regulus Therapeutics is headquartered in San Diego, California, the US.

Regulus Therapeutics Inc. Key Recent Developments

Dec 23, 2013: Regulus Announces Addition to NASDAQ Biotechnology Index
Nov 20, 2013: Regulus Demonstrates Initial Progress in microRNA Biomarkers MS Collaboration and Receives Milestone Payment from Biogen
Nov 13, 2013: Regulus reports third quarter 2013 financial results and recent highlights
Nov 06, 2013: Regulus Announces Timing for Third Quarter 2013 Financial Results Webcast and Conference Call
Aug 13, 2013: Regulus Reports Second Quarter 2013 Financial Results and Recent Highlights

This comprehensive SWOT profile of Regulus Therapeutics Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Regulus Therapeutics Inc. including: and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief Summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Publisher Name : GlobalData


Section 1 - About the Company

Regulus Therapeutics Inc. - Key Information
Regulus Therapeutics Inc. - Overview
Regulus Therapeutics Inc. - Key Employees
Regulus Therapeutics Inc. - Key Employee Biographies
Regulus Therapeutics Inc. - Key Operational Heads
Regulus Therapeutics Inc. - Major Products and Services
Regulus Therapeutics Inc. - History
Regulus Therapeutics Inc. - Company Statement
Regulus Therapeutics Inc. - Locations And Subsidiaries
Regulus Therapeutics Inc. - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Regulus Therapeutics Inc. - Business Description
Regulus Therapeutics Inc. - Corporate Strategy
Regulus Therapeutics Inc. - SWOT Analysis
SWOT Analysis - Overview
Regulus Therapeutics Inc. - Strengths
Regulus Therapeutics Inc. - Weaknesses
Regulus Therapeutics Inc. - Opportunities
Regulus Therapeutics Inc. - Threats
Regulus Therapeutics Inc. - Key Competitors

Section 3 - Company Financial Performance Charts

Regulus Therapeutics Inc. - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company



List Of Tables

Regulus Therapeutics Inc., Key Information
Regulus Therapeutics Inc., Key Ratios
Regulus Therapeutics Inc., Share Data
Regulus Therapeutics Inc., Major Products and Services
Regulus Therapeutics Inc., History
Regulus Therapeutics Inc., Key Employees
Regulus Therapeutics Inc., Key Employee Biographies
Regulus Therapeutics Inc., Key Operational Heads
Regulus Therapeutics Inc., Other Locations
Regulus Therapeutics Inc., Subsidiaries
Regulus Therapeutics Inc., Key Manufacturing facilities
Regulus Therapeutics Inc., Key Competitors
Regulus Therapeutics Inc., SWOT Analysis
Regulus Therapeutics Inc., Ratios based on current share price
Regulus Therapeutics Inc., Annual Ratios
Regulus Therapeutics Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios



List Of Figures

Regulus Therapeutics Inc., Performance Chart
Regulus Therapeutics Inc., Ratio Charts



Regulus Therapeutics Inc (Regulus Therapeutics) is a developer of microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of

View Report

Regulus Therapeutics Inc (Regulus Therapeutics) is a developer of microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of

View Report

Regulus Therapeutics Inc. (RGLS) - Financial and Strategic SWOT Analysis Review market research report at USD 300 and market update available at JSB Market Research.

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports